Vincerx Pharma, Inc. Financing Cash Flow
Vincerx Pharma, Inc. reported Financing Cash Flow of $3.86 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-05-15
- Vincerx Pharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $3.86M, a 77020.00% increase year-over-year.
- Vincerx Pharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $985.00K, a 5372.22% increase year-over-year.
- Vincerx Pharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $0.00.
- Vincerx Pharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $17.00M, a 18181.72% increase year-over-year.
- Vincerx Pharma, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $17.99M, a 15682.46% increase from fiscal 2023.
- Vincerx Pharma, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $114.00K, a 59.29% decline from fiscal 2022.
- Vincerx Pharma, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $280.00K, a 99.68% decline from fiscal 2021.
- Vincerx Pharma, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $88.45M, a 38.05% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2025-03-31 | $3.86M 10-Q · filed 2025-05-15 | $4.84M derived: sum of 2 quarters · filed 2025-05-15 | $4.84M derived: sum of 3 quarters · filed 2025-05-15 | $21.84M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $985.00K derived: sum of 2 quarters · filed 2025-03-27 | $17.99M derived: sum of 3 quarters · filed 2025-03-27 | $17.99M 10-K · filed 2025-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $17.00M derived: sum of 2 quarters · filed 2024-11-12 | $17.01M 10-Q · filed 2024-11-12 | $17.02M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $17.01M 10-Q · filed 2024-08-08 | $17.02M derived: sum of 3 quarters · filed 2025-05-15 | $17.02M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-15 | $23.00K derived: sum of 2 quarters · filed 2025-05-15 | $23.00K derived: sum of 3 quarters · filed 2025-05-15 | $116.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $18.00K derived: sum of 2 quarters · filed 2025-03-27 | $111.00K derived: sum of 3 quarters · filed 2025-03-27 | $114.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $93.00K derived: sum of 2 quarters · filed 2024-11-12 | $96.00K 10-Q · filed 2024-11-12 | $134.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $96.00K 10-Q · filed 2024-08-08 | $134.00K derived: sum of 3 quarters · filed 2024-08-08 | $134.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $3.00K 10-Q · filed 2024-05-14 | $41.00K derived: sum of 2 quarters · filed 2024-05-14 | $41.00K derived: sum of 3 quarters · filed 2024-05-14 | $283.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $38.00K derived: sum of 2 quarters · filed 2024-03-29 | $280.00K derived: sum of 3 quarters · filed 2024-03-29 | $280.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $242.00K derived: sum of 2 quarters · filed 2023-11-14 | $242.00K 10-Q · filed 2023-11-14 | $525.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $242.00K 10-Q · filed 2023-08-07 | $525.00K derived: sum of 3 quarters · filed 2023-08-07 | $48.02M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $283.00K derived: sum of 2 quarters · filed 2023-05-11 | $47.78M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $47.78M derived: sum of 2 quarters · filed 2023-03-28 | $88.45M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $47.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $88.17M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $40.67M 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $63.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $64.07M 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $180.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | $66.46M 10-K · filed 2020-09-23 | ||
| 2020-03-31 | $66.46M 10-Q · filed 2020-05-06 | |||
| 2019-06-30 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2020-09-23 | $25.00K 10-K · filed 2020-09-23 | ||
| 2019-03-31 | $25.00K 10-Q · filed 2020-05-06 |